Bisaramil

This classification denotes an antiarrhythmic agent with the molecular formula C17H23ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) FVT2ESG270, chemically known as syn-3-ethyl-7-methyl-3,7-diazabicyclo(3.3.1)non-9-yl p-chlorobenzoate but more generally known as bisaramil, which bears US NIH Compound Identifier 3033742. Bisaramil most often comes in base and hydrochloride forms. European Medicines Agency schedules Bisaramil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05848MIG. The term BISARAMIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). BISARAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bisaramil under HS 29333999 and SITC 51574. As of Q4 2014, BISARAMIL remains US FDA's Preferred Term for this commodity. Bisaramil bears US NLM identifiers UMLS ID C0106533 and NCI Concept Code C81430. SMILES: CLC1CCC(C(=O)OC2C3CN(CC2CN(C3)C)CC)CC1.